A virtual fireside chat with Schulich ExecEd Executive Director Alan Middleton and Ronnie Miller, President and CEO of Roche Pharma Canada on leadership in a crisis.
Leadership Lessons: A View from the Top
Monday, April 27, 2020, 11am
Ronnie Miller, President and CEO of Roche Pharma Canada
In the second of a new online speaker series, Miller will talk with Schulich ExecEd Executive Director Alan Middleton from 11-11:30am. Miller will touch on Roche Canada’s new “COVID-19 Open Innovation Challenge”, a funding program launched this month to support the Canadian community to bring forward innovative ideas and solutions to address some of the biggest challenges created by the pandemic.
We live in a new world. Each day we are faced with uncertainty and disruption. With these new business challenges come new opportunities for your organization to transform and succeed.
What lessons can we learn from this new reality? How can we be resilient and improve as an individual, team and organization during a crisis?
These and other important questions will be explored during a series of virtual fireside chats: Leadership Lessons in Troubled Times. These free, 30-minute online events will feature thought leaders and influencers from top organizations in the public, private and not-for-profit sectors.
The speakers will share their insights on leadership lessons learned and how they might apply to your business or organization:
- What are the most important leadership traits for a company or organization during disruption?
- How do you build up resilience in different functions across your team and organization?
- What strategies are needed to communicate new ideas and shift mindsets (social distancing, telework, managing remote teams, innovation)?
- How do you overcome resistance to change on an individual, team and organizational level?
- How do we improve collaboration and stakeholder management during a crisis?
Get information on the complete Leadership Lessons in Troubled Times, Fireside Chat Series, here.
About Alan’s Guest
Ronnie Miller is president and CEO of Hoffmann-La Roche Limited (Roche Canada). In this role, he is responsible for the growth and success of the Canadian Pharmaceuticals Division, particularly as it relates to the company’s mandate of developing and delivering innovative healthcare solutions for Canadians.
Ronnie has more than 40 years of extensive and varied experience in the pharmaceutical industry. After completing his Bachelor of Science in Economics and Geography at the University of Glasgow, Ronnie moved to London to accept a job as a pharmaceutical sales representative. He advanced through a series of successive sales and management positions across the industry working in Switzerland and Japan. Ronnie was appointed President and CEO of Roche Pharmaceuticals in Canada in April 2000.
Ronnie was recently re-elected as the Chairman of the Board of Directors of Innovative Medicines Canada (IMC), the national association representing Canada’s research-based pharmaceutical companies. He was previously Chairman of the IMC Board in 2007 and has since fulfilled two subsequent terms as Past Chair.
The Schulich ExecEd is committed to working in partnership with organizations adapting to the demands of doing business in a virtual world. For more information on how Schulich ExecEd can help your organization respond in troubled times, visit our web page, Schulich ExecEd: Your Business Continuity and Learning Partner.